nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—Vismodegib—Sulfasalazine—rheumatoid arthritis	0.408	1	CrCrCtD
Etoricoxib—PTGS2—rheumatoid arthritis	0.131	1	CbGaD
Etoricoxib—PTGS2—Sulfasalazine—rheumatoid arthritis	0.0328	0.122	CbGbCtD
Etoricoxib—PTGS2—Triamcinolone—rheumatoid arthritis	0.0328	0.122	CbGbCtD
Etoricoxib—PTGS2—Betamethasone—rheumatoid arthritis	0.0281	0.104	CbGbCtD
Etoricoxib—CYP1A2—Leflunomide—rheumatoid arthritis	0.02	0.0743	CbGbCtD
Etoricoxib—CYP2C9—Leflunomide—rheumatoid arthritis	0.018	0.067	CbGbCtD
Etoricoxib—PTGS2—Dexamethasone—rheumatoid arthritis	0.0163	0.0607	CbGbCtD
Etoricoxib—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0116	0.0431	CbGbCtD
Etoricoxib—CYP2C19—Prednisone—rheumatoid arthritis	0.0107	0.0398	CbGbCtD
Etoricoxib—CYP2E1—Dexamethasone—rheumatoid arthritis	0.0107	0.0396	CbGbCtD
Etoricoxib—CYP2C19—Cyclosporine—rheumatoid arthritis	0.0101	0.0377	CbGbCtD
Etoricoxib—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00854	0.0317	CbGbCtD
Etoricoxib—CYP2C9—Cyclosporine—rheumatoid arthritis	0.00844	0.0314	CbGbCtD
Etoricoxib—CYP2D6—Cyclosporine—rheumatoid arthritis	0.00772	0.0287	CbGbCtD
Etoricoxib—CYP2C19—Dexamethasone—rheumatoid arthritis	0.00668	0.0248	CbGbCtD
Etoricoxib—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00647	0.0241	CbGbCtD
Etoricoxib—CYP2C9—Dexamethasone—rheumatoid arthritis	0.00556	0.0206	CbGbCtD
Etoricoxib—CYP3A4—Betamethasone—rheumatoid arthritis	0.00555	0.0206	CbGbCtD
Etoricoxib—CYP3A4—Prednisolone—rheumatoid arthritis	0.00548	0.0204	CbGbCtD
Etoricoxib—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00519	0.0193	CbGbCtD
Etoricoxib—CYP3A4—Prednisone—rheumatoid arthritis	0.00518	0.0192	CbGbCtD
Etoricoxib—CYP2D6—Dexamethasone—rheumatoid arthritis	0.00508	0.0189	CbGbCtD
Etoricoxib—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00491	0.0182	CbGbCtD
Etoricoxib—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00323	0.012	CbGbCtD
Etoricoxib—Vemurafenib—ALB—rheumatoid arthritis	0.000533	0.364	CrCbGaD
Etoricoxib—Celecoxib—PTGS2—rheumatoid arthritis	0.000352	0.24	CrCbGaD
Etoricoxib—PTGS2—Fluocinonide—Methylprednisolone—rheumatoid arthritis	0.00032	0.159	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Betamethasone—rheumatoid arthritis	0.000315	0.156	CbGdCrCtD
Etoricoxib—PTGS2—Fluocinonide—Dexamethasone—rheumatoid arthritis	0.000315	0.156	CbGdCrCtD
Etoricoxib—Celecoxib—ALB—rheumatoid arthritis	0.000313	0.214	CrCbGaD
Etoricoxib—PTGS2—Fluocinonide—Triamcinolone—rheumatoid arthritis	0.000308	0.153	CbGdCrCtD
Etoricoxib—Vismodegib—ALB—rheumatoid arthritis	0.000268	0.183	CrCbGaD
Etoricoxib—PTGS2—Fluticasone Propionate—Methylprednisolone—rheumatoid arthritis	0.000193	0.0958	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Betamethasone—rheumatoid arthritis	0.00019	0.0943	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Dexamethasone—rheumatoid arthritis	0.00019	0.0943	CbGdCrCtD
Etoricoxib—PTGS2—Fluticasone Propionate—Triamcinolone—rheumatoid arthritis	0.000186	0.0921	CbGdCrCtD
Etoricoxib—Oedema—Triamcinolone—rheumatoid arthritis	5.42e-05	0.000499	CcSEcCtD
Etoricoxib—Anaphylactic shock—Methylprednisolone—rheumatoid arthritis	5.4e-05	0.000498	CcSEcCtD
Etoricoxib—Arrhythmia—Prednisone—rheumatoid arthritis	5.38e-05	0.000496	CcSEcCtD
Etoricoxib—Infection—Triamcinolone—rheumatoid arthritis	5.38e-05	0.000495	CcSEcCtD
Etoricoxib—Infection—Methylprednisolone—rheumatoid arthritis	5.37e-05	0.000494	CcSEcCtD
Etoricoxib—Haematuria—Methotrexate—rheumatoid arthritis	5.35e-05	0.000492	CcSEcCtD
Etoricoxib—Feeling abnormal—Cyclosporine—rheumatoid arthritis	5.33e-05	0.000491	CcSEcCtD
Etoricoxib—Vomiting—Leflunomide—rheumatoid arthritis	5.33e-05	0.000491	CcSEcCtD
Etoricoxib—Shock—Triamcinolone—rheumatoid arthritis	5.33e-05	0.000491	CcSEcCtD
Etoricoxib—Insomnia—Prednisolone—rheumatoid arthritis	5.33e-05	0.000491	CcSEcCtD
Etoricoxib—Alopecia—Prednisone—rheumatoid arthritis	5.32e-05	0.00049	CcSEcCtD
Etoricoxib—Shock—Methylprednisolone—rheumatoid arthritis	5.32e-05	0.00049	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Methotrexate—rheumatoid arthritis	5.3e-05	0.000488	CcSEcCtD
Etoricoxib—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	5.3e-05	0.000488	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	5.29e-05	0.000487	CcSEcCtD
Etoricoxib—Epistaxis—Methotrexate—rheumatoid arthritis	5.29e-05	0.000487	CcSEcCtD
Etoricoxib—Rash—Leflunomide—rheumatoid arthritis	5.29e-05	0.000487	CcSEcCtD
Etoricoxib—Dermatitis—Leflunomide—rheumatoid arthritis	5.28e-05	0.000486	CcSEcCtD
Etoricoxib—Mental disorder—Prednisone—rheumatoid arthritis	5.28e-05	0.000486	CcSEcCtD
Etoricoxib—Nausea—Azathioprine—rheumatoid arthritis	5.28e-05	0.000486	CcSEcCtD
Etoricoxib—Headache—Leflunomide—rheumatoid arthritis	5.25e-05	0.000484	CcSEcCtD
Etoricoxib—Skin disorder—Methylprednisolone—rheumatoid arthritis	5.25e-05	0.000483	CcSEcCtD
Etoricoxib—Malnutrition—Prednisone—rheumatoid arthritis	5.24e-05	0.000483	CcSEcCtD
Etoricoxib—Erythema—Prednisone—rheumatoid arthritis	5.24e-05	0.000483	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	5.24e-05	0.000483	CcSEcCtD
Etoricoxib—Insomnia—Hydrocortisone—rheumatoid arthritis	5.2e-05	0.000479	CcSEcCtD
Etoricoxib—Hypertension—Dexamethasone—rheumatoid arthritis	5.2e-05	0.000479	CcSEcCtD
Etoricoxib—Hypertension—Betamethasone—rheumatoid arthritis	5.2e-05	0.000479	CcSEcCtD
Etoricoxib—Urticaria—Cyclosporine—rheumatoid arthritis	5.14e-05	0.000473	CcSEcCtD
Etoricoxib—Abdominal pain—Cyclosporine—rheumatoid arthritis	5.12e-05	0.000471	CcSEcCtD
Etoricoxib—Anxiety—Betamethasone—rheumatoid arthritis	5.11e-05	0.00047	CcSEcCtD
Etoricoxib—Anxiety—Dexamethasone—rheumatoid arthritis	5.11e-05	0.00047	CcSEcCtD
Etoricoxib—Dyspepsia—Hydrocortisone—rheumatoid arthritis	5.06e-05	0.000466	CcSEcCtD
Etoricoxib—Haemoglobin—Methotrexate—rheumatoid arthritis	5.06e-05	0.000466	CcSEcCtD
Etoricoxib—Pain—Prednisolone—rheumatoid arthritis	5.04e-05	0.000464	CcSEcCtD
Etoricoxib—Hepatitis—Methotrexate—rheumatoid arthritis	5.04e-05	0.000464	CcSEcCtD
Etoricoxib—Haemorrhage—Methotrexate—rheumatoid arthritis	5.04e-05	0.000464	CcSEcCtD
Etoricoxib—Decreased appetite—Hydrocortisone—rheumatoid arthritis	5e-05	0.00046	CcSEcCtD
Etoricoxib—Pharyngitis—Methotrexate—rheumatoid arthritis	5e-05	0.00046	CcSEcCtD
Etoricoxib—Nausea—Leflunomide—rheumatoid arthritis	4.98e-05	0.000459	CcSEcCtD
Etoricoxib—Urinary tract disorder—Methotrexate—rheumatoid arthritis	4.97e-05	0.000458	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	4.97e-05	0.000457	CcSEcCtD
Etoricoxib—Fatigue—Hydrocortisone—rheumatoid arthritis	4.96e-05	0.000457	CcSEcCtD
Etoricoxib—Vision blurred—Prednisone—rheumatoid arthritis	4.94e-05	0.000455	CcSEcCtD
Etoricoxib—Urethral disorder—Methotrexate—rheumatoid arthritis	4.94e-05	0.000454	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	4.94e-05	0.000454	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	4.92e-05	0.000453	CcSEcCtD
Etoricoxib—Pain—Hydrocortisone—rheumatoid arthritis	4.92e-05	0.000453	CcSEcCtD
Etoricoxib—Oedema—Dexamethasone—rheumatoid arthritis	4.92e-05	0.000453	CcSEcCtD
Etoricoxib—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	4.92e-05	0.000453	CcSEcCtD
Etoricoxib—Oedema—Betamethasone—rheumatoid arthritis	4.92e-05	0.000453	CcSEcCtD
Etoricoxib—Anaphylactic shock—Betamethasone—rheumatoid arthritis	4.92e-05	0.000453	CcSEcCtD
Etoricoxib—Insomnia—Triamcinolone—rheumatoid arthritis	4.9e-05	0.000451	CcSEcCtD
Etoricoxib—Insomnia—Methylprednisolone—rheumatoid arthritis	4.89e-05	0.00045	CcSEcCtD
Etoricoxib—Infection—Betamethasone—rheumatoid arthritis	4.88e-05	0.00045	CcSEcCtD
Etoricoxib—Infection—Dexamethasone—rheumatoid arthritis	4.88e-05	0.00045	CcSEcCtD
Etoricoxib—Feeling abnormal—Prednisolone—rheumatoid arthritis	4.85e-05	0.000447	CcSEcCtD
Etoricoxib—Visual impairment—Methotrexate—rheumatoid arthritis	4.85e-05	0.000447	CcSEcCtD
Etoricoxib—Anaemia—Prednisone—rheumatoid arthritis	4.85e-05	0.000446	CcSEcCtD
Etoricoxib—Shock—Dexamethasone—rheumatoid arthritis	4.84e-05	0.000445	CcSEcCtD
Etoricoxib—Shock—Betamethasone—rheumatoid arthritis	4.84e-05	0.000445	CcSEcCtD
Etoricoxib—Dyspnoea—Triamcinolone—rheumatoid arthritis	4.83e-05	0.000445	CcSEcCtD
Etoricoxib—Nervous system disorder—Dexamethasone—rheumatoid arthritis	4.82e-05	0.000444	CcSEcCtD
Etoricoxib—Nervous system disorder—Betamethasone—rheumatoid arthritis	4.82e-05	0.000444	CcSEcCtD
Etoricoxib—Agitation—Prednisone—rheumatoid arthritis	4.82e-05	0.000444	CcSEcCtD
Etoricoxib—Thrombocytopenia—Betamethasone—rheumatoid arthritis	4.81e-05	0.000443	CcSEcCtD
Etoricoxib—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	4.81e-05	0.000443	CcSEcCtD
Etoricoxib—Angioedema—Prednisone—rheumatoid arthritis	4.79e-05	0.000441	CcSEcCtD
Etoricoxib—Hypersensitivity—Cyclosporine—rheumatoid arthritis	4.77e-05	0.000439	CcSEcCtD
Etoricoxib—Dyspepsia—Triamcinolone—rheumatoid arthritis	4.77e-05	0.000439	CcSEcCtD
Etoricoxib—Erythema multiforme—Methotrexate—rheumatoid arthritis	4.76e-05	0.000438	CcSEcCtD
Etoricoxib—Dyspepsia—Methylprednisolone—rheumatoid arthritis	4.76e-05	0.000438	CcSEcCtD
Etoricoxib—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	4.74e-05	0.000436	CcSEcCtD
Etoricoxib—Eye disorder—Methotrexate—rheumatoid arthritis	4.71e-05	0.000433	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	4.7e-05	0.000433	CcSEcCtD
Etoricoxib—Tinnitus—Methotrexate—rheumatoid arthritis	4.69e-05	0.000432	CcSEcCtD
Etoricoxib—Anorexia—Dexamethasone—rheumatoid arthritis	4.69e-05	0.000431	CcSEcCtD
Etoricoxib—Anorexia—Betamethasone—rheumatoid arthritis	4.69e-05	0.000431	CcSEcCtD
Etoricoxib—Urticaria—Prednisolone—rheumatoid arthritis	4.68e-05	0.000431	CcSEcCtD
Etoricoxib—Cardiac disorder—Methotrexate—rheumatoid arthritis	4.67e-05	0.00043	CcSEcCtD
Etoricoxib—Fatigue—Triamcinolone—rheumatoid arthritis	4.67e-05	0.00043	CcSEcCtD
Etoricoxib—Fatigue—Methylprednisolone—rheumatoid arthritis	4.66e-05	0.000429	CcSEcCtD
Etoricoxib—Asthenia—Cyclosporine—rheumatoid arthritis	4.64e-05	0.000428	CcSEcCtD
Etoricoxib—Pain—Triamcinolone—rheumatoid arthritis	4.63e-05	0.000426	CcSEcCtD
Etoricoxib—Pruritus—Cyclosporine—rheumatoid arthritis	4.58e-05	0.000422	CcSEcCtD
Etoricoxib—Urticaria—Hydrocortisone—rheumatoid arthritis	4.57e-05	0.000421	CcSEcCtD
Etoricoxib—Angiopathy—Methotrexate—rheumatoid arthritis	4.57e-05	0.000421	CcSEcCtD
Etoricoxib—Immune system disorder—Methotrexate—rheumatoid arthritis	4.55e-05	0.000419	CcSEcCtD
Etoricoxib—Abdominal pain—Hydrocortisone—rheumatoid arthritis	4.55e-05	0.000419	CcSEcCtD
Etoricoxib—Mediastinal disorder—Methotrexate—rheumatoid arthritis	4.54e-05	0.000418	CcSEcCtD
Etoricoxib—Hypertension—Prednisone—rheumatoid arthritis	4.53e-05	0.000417	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	4.48e-05	0.000412	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	4.48e-05	0.000412	CcSEcCtD
Etoricoxib—Arthralgia—Prednisone—rheumatoid arthritis	4.47e-05	0.000411	CcSEcCtD
Etoricoxib—Feeling abnormal—Triamcinolone—rheumatoid arthritis	4.46e-05	0.000411	CcSEcCtD
Etoricoxib—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	4.45e-05	0.00041	CcSEcCtD
Etoricoxib—Anxiety—Prednisone—rheumatoid arthritis	4.45e-05	0.00041	CcSEcCtD
Etoricoxib—Alopecia—Methotrexate—rheumatoid arthritis	4.45e-05	0.00041	CcSEcCtD
Etoricoxib—Insomnia—Dexamethasone—rheumatoid arthritis	4.45e-05	0.000409	CcSEcCtD
Etoricoxib—Insomnia—Betamethasone—rheumatoid arthritis	4.45e-05	0.000409	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	4.43e-05	0.000408	CcSEcCtD
Etoricoxib—Diarrhoea—Cyclosporine—rheumatoid arthritis	4.43e-05	0.000408	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	4.42e-05	0.000407	CcSEcCtD
Etoricoxib—Mental disorder—Methotrexate—rheumatoid arthritis	4.41e-05	0.000406	CcSEcCtD
Etoricoxib—Erythema—Methotrexate—rheumatoid arthritis	4.38e-05	0.000404	CcSEcCtD
Etoricoxib—Malnutrition—Methotrexate—rheumatoid arthritis	4.38e-05	0.000404	CcSEcCtD
Etoricoxib—Hypersensitivity—Prednisolone—rheumatoid arthritis	4.34e-05	0.0004	CcSEcCtD
Etoricoxib—Dyspepsia—Dexamethasone—rheumatoid arthritis	4.33e-05	0.000398	CcSEcCtD
Etoricoxib—Dyspepsia—Betamethasone—rheumatoid arthritis	4.33e-05	0.000398	CcSEcCtD
Etoricoxib—Urticaria—Triamcinolone—rheumatoid arthritis	4.3e-05	0.000396	CcSEcCtD
Etoricoxib—Urticaria—Methylprednisolone—rheumatoid arthritis	4.29e-05	0.000395	CcSEcCtD
Etoricoxib—Dysgeusia—Methotrexate—rheumatoid arthritis	4.29e-05	0.000395	CcSEcCtD
Etoricoxib—Dizziness—Cyclosporine—rheumatoid arthritis	4.28e-05	0.000394	CcSEcCtD
Etoricoxib—Anaphylactic shock—Prednisone—rheumatoid arthritis	4.28e-05	0.000394	CcSEcCtD
Etoricoxib—Oedema—Prednisone—rheumatoid arthritis	4.28e-05	0.000394	CcSEcCtD
Etoricoxib—Abdominal pain—Methylprednisolone—rheumatoid arthritis	4.27e-05	0.000393	CcSEcCtD
Etoricoxib—Decreased appetite—Dexamethasone—rheumatoid arthritis	4.27e-05	0.000393	CcSEcCtD
Etoricoxib—Decreased appetite—Betamethasone—rheumatoid arthritis	4.27e-05	0.000393	CcSEcCtD
Etoricoxib—Infection—Prednisone—rheumatoid arthritis	4.25e-05	0.000392	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	4.24e-05	0.000391	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	4.24e-05	0.000391	CcSEcCtD
Etoricoxib—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	4.24e-05	0.00039	CcSEcCtD
Etoricoxib—Fatigue—Dexamethasone—rheumatoid arthritis	4.24e-05	0.00039	CcSEcCtD
Etoricoxib—Fatigue—Betamethasone—rheumatoid arthritis	4.24e-05	0.00039	CcSEcCtD
Etoricoxib—Shock—Prednisone—rheumatoid arthritis	4.21e-05	0.000388	CcSEcCtD
Etoricoxib—Pain—Betamethasone—rheumatoid arthritis	4.2e-05	0.000387	CcSEcCtD
Etoricoxib—Pain—Dexamethasone—rheumatoid arthritis	4.2e-05	0.000387	CcSEcCtD
Etoricoxib—Nervous system disorder—Prednisone—rheumatoid arthritis	4.2e-05	0.000386	CcSEcCtD
Etoricoxib—Skin disorder—Prednisone—rheumatoid arthritis	4.16e-05	0.000383	CcSEcCtD
Etoricoxib—Vision blurred—Methotrexate—rheumatoid arthritis	4.13e-05	0.00038	CcSEcCtD
Etoricoxib—Asthenia—Hydrocortisone—rheumatoid arthritis	4.13e-05	0.00038	CcSEcCtD
Etoricoxib—Vomiting—Cyclosporine—rheumatoid arthritis	4.12e-05	0.000379	CcSEcCtD
Etoricoxib—Rash—Cyclosporine—rheumatoid arthritis	4.08e-05	0.000376	CcSEcCtD
Etoricoxib—Anorexia—Prednisone—rheumatoid arthritis	4.08e-05	0.000376	CcSEcCtD
Etoricoxib—Dermatitis—Cyclosporine—rheumatoid arthritis	4.08e-05	0.000375	CcSEcCtD
Etoricoxib—Pruritus—Hydrocortisone—rheumatoid arthritis	4.07e-05	0.000375	CcSEcCtD
Etoricoxib—Headache—Cyclosporine—rheumatoid arthritis	4.06e-05	0.000373	CcSEcCtD
Etoricoxib—Anaemia—Methotrexate—rheumatoid arthritis	4.05e-05	0.000373	CcSEcCtD
Etoricoxib—Feeling abnormal—Dexamethasone—rheumatoid arthritis	4.05e-05	0.000373	CcSEcCtD
Etoricoxib—Feeling abnormal—Betamethasone—rheumatoid arthritis	4.05e-05	0.000373	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	4.02e-05	0.00037	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	4.02e-05	0.00037	CcSEcCtD
Etoricoxib—Hypersensitivity—Triamcinolone—rheumatoid arthritis	3.99e-05	0.000367	CcSEcCtD
Etoricoxib—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	3.98e-05	0.000367	CcSEcCtD
Etoricoxib—Diarrhoea—Hydrocortisone—rheumatoid arthritis	3.94e-05	0.000362	CcSEcCtD
Etoricoxib—Urticaria—Dexamethasone—rheumatoid arthritis	3.9e-05	0.000359	CcSEcCtD
Etoricoxib—Urticaria—Betamethasone—rheumatoid arthritis	3.9e-05	0.000359	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	3.9e-05	0.000359	CcSEcCtD
Etoricoxib—Dizziness—Prednisolone—rheumatoid arthritis	3.9e-05	0.000359	CcSEcCtD
Etoricoxib—Asthenia—Triamcinolone—rheumatoid arthritis	3.89e-05	0.000358	CcSEcCtD
Etoricoxib—Abdominal pain—Betamethasone—rheumatoid arthritis	3.89e-05	0.000358	CcSEcCtD
Etoricoxib—Abdominal pain—Dexamethasone—rheumatoid arthritis	3.89e-05	0.000358	CcSEcCtD
Etoricoxib—Asthenia—Methylprednisolone—rheumatoid arthritis	3.88e-05	0.000357	CcSEcCtD
Etoricoxib—Insomnia—Prednisone—rheumatoid arthritis	3.87e-05	0.000356	CcSEcCtD
Etoricoxib—Nausea—Cyclosporine—rheumatoid arthritis	3.85e-05	0.000354	CcSEcCtD
Etoricoxib—Pruritus—Triamcinolone—rheumatoid arthritis	3.83e-05	0.000353	CcSEcCtD
Etoricoxib—Cough—Methotrexate—rheumatoid arthritis	3.82e-05	0.000352	CcSEcCtD
Etoricoxib—Pruritus—Methylprednisolone—rheumatoid arthritis	3.82e-05	0.000352	CcSEcCtD
Etoricoxib—Dizziness—Hydrocortisone—rheumatoid arthritis	3.8e-05	0.00035	CcSEcCtD
Etoricoxib—Dyspepsia—Prednisone—rheumatoid arthritis	3.77e-05	0.000347	CcSEcCtD
Etoricoxib—Arthralgia—Methotrexate—rheumatoid arthritis	3.73e-05	0.000344	CcSEcCtD
Etoricoxib—Chest pain—Methotrexate—rheumatoid arthritis	3.73e-05	0.000344	CcSEcCtD
Etoricoxib—Decreased appetite—Prednisone—rheumatoid arthritis	3.72e-05	0.000343	CcSEcCtD
Etoricoxib—Rash—Prednisolone—rheumatoid arthritis	3.71e-05	0.000342	CcSEcCtD
Etoricoxib—Dermatitis—Prednisolone—rheumatoid arthritis	3.71e-05	0.000342	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	3.71e-05	0.000341	CcSEcCtD
Etoricoxib—Diarrhoea—Methylprednisolone—rheumatoid arthritis	3.7e-05	0.00034	CcSEcCtD
Etoricoxib—Fatigue—Prednisone—rheumatoid arthritis	3.69e-05	0.00034	CcSEcCtD
Etoricoxib—Headache—Prednisolone—rheumatoid arthritis	3.69e-05	0.00034	CcSEcCtD
Etoricoxib—Constipation—Prednisone—rheumatoid arthritis	3.66e-05	0.000337	CcSEcCtD
Etoricoxib—Vomiting—Hydrocortisone—rheumatoid arthritis	3.66e-05	0.000337	CcSEcCtD
Etoricoxib—Rash—Hydrocortisone—rheumatoid arthritis	3.63e-05	0.000334	CcSEcCtD
Etoricoxib—Dermatitis—Hydrocortisone—rheumatoid arthritis	3.62e-05	0.000334	CcSEcCtD
Etoricoxib—Confusional state—Methotrexate—rheumatoid arthritis	3.61e-05	0.000332	CcSEcCtD
Etoricoxib—Headache—Hydrocortisone—rheumatoid arthritis	3.6e-05	0.000332	CcSEcCtD
Etoricoxib—Dizziness—Triamcinolone—rheumatoid arthritis	3.58e-05	0.00033	CcSEcCtD
Etoricoxib—Anaphylactic shock—Methotrexate—rheumatoid arthritis	3.58e-05	0.000329	CcSEcCtD
Etoricoxib—Dizziness—Methylprednisolone—rheumatoid arthritis	3.57e-05	0.000329	CcSEcCtD
Etoricoxib—Infection—Methotrexate—rheumatoid arthritis	3.55e-05	0.000327	CcSEcCtD
Etoricoxib—Feeling abnormal—Prednisone—rheumatoid arthritis	3.53e-05	0.000325	CcSEcCtD
Etoricoxib—Asthenia—Betamethasone—rheumatoid arthritis	3.53e-05	0.000325	CcSEcCtD
Etoricoxib—Asthenia—Dexamethasone—rheumatoid arthritis	3.53e-05	0.000325	CcSEcCtD
Etoricoxib—Nervous system disorder—Methotrexate—rheumatoid arthritis	3.51e-05	0.000323	CcSEcCtD
Etoricoxib—Thrombocytopenia—Methotrexate—rheumatoid arthritis	3.5e-05	0.000322	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Prednisone—rheumatoid arthritis	3.5e-05	0.000322	CcSEcCtD
Etoricoxib—Nausea—Prednisolone—rheumatoid arthritis	3.5e-05	0.000322	CcSEcCtD
Etoricoxib—Pruritus—Dexamethasone—rheumatoid arthritis	3.48e-05	0.00032	CcSEcCtD
Etoricoxib—Pruritus—Betamethasone—rheumatoid arthritis	3.48e-05	0.00032	CcSEcCtD
Etoricoxib—Skin disorder—Methotrexate—rheumatoid arthritis	3.47e-05	0.00032	CcSEcCtD
Etoricoxib—Vomiting—Triamcinolone—rheumatoid arthritis	3.44e-05	0.000317	CcSEcCtD
Etoricoxib—Vomiting—Methylprednisolone—rheumatoid arthritis	3.44e-05	0.000316	CcSEcCtD
Etoricoxib—Nausea—Hydrocortisone—rheumatoid arthritis	3.42e-05	0.000315	CcSEcCtD
Etoricoxib—Rash—Triamcinolone—rheumatoid arthritis	3.42e-05	0.000314	CcSEcCtD
Etoricoxib—Dermatitis—Triamcinolone—rheumatoid arthritis	3.41e-05	0.000314	CcSEcCtD
Etoricoxib—Anorexia—Methotrexate—rheumatoid arthritis	3.41e-05	0.000314	CcSEcCtD
Etoricoxib—Rash—Methylprednisolone—rheumatoid arthritis	3.41e-05	0.000314	CcSEcCtD
Etoricoxib—Dermatitis—Methylprednisolone—rheumatoid arthritis	3.4e-05	0.000313	CcSEcCtD
Etoricoxib—Urticaria—Prednisone—rheumatoid arthritis	3.4e-05	0.000313	CcSEcCtD
Etoricoxib—Headache—Triamcinolone—rheumatoid arthritis	3.39e-05	0.000312	CcSEcCtD
Etoricoxib—Headache—Methylprednisolone—rheumatoid arthritis	3.39e-05	0.000312	CcSEcCtD
Etoricoxib—Abdominal pain—Prednisone—rheumatoid arthritis	3.38e-05	0.000312	CcSEcCtD
Etoricoxib—Diarrhoea—Betamethasone—rheumatoid arthritis	3.36e-05	0.00031	CcSEcCtD
Etoricoxib—Diarrhoea—Dexamethasone—rheumatoid arthritis	3.36e-05	0.00031	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	3.26e-05	0.0003	CcSEcCtD
Etoricoxib—Dizziness—Betamethasone—rheumatoid arthritis	3.25e-05	0.000299	CcSEcCtD
Etoricoxib—Dizziness—Dexamethasone—rheumatoid arthritis	3.25e-05	0.000299	CcSEcCtD
Etoricoxib—Insomnia—Methotrexate—rheumatoid arthritis	3.24e-05	0.000298	CcSEcCtD
Etoricoxib—Nausea—Triamcinolone—rheumatoid arthritis	3.22e-05	0.000296	CcSEcCtD
Etoricoxib—Nausea—Methylprednisolone—rheumatoid arthritis	3.21e-05	0.000296	CcSEcCtD
Etoricoxib—Dyspnoea—Methotrexate—rheumatoid arthritis	3.19e-05	0.000294	CcSEcCtD
Etoricoxib—Somnolence—Methotrexate—rheumatoid arthritis	3.18e-05	0.000293	CcSEcCtD
Etoricoxib—Hypersensitivity—Prednisone—rheumatoid arthritis	3.15e-05	0.00029	CcSEcCtD
Etoricoxib—Dyspepsia—Methotrexate—rheumatoid arthritis	3.15e-05	0.00029	CcSEcCtD
Etoricoxib—Vomiting—Betamethasone—rheumatoid arthritis	3.13e-05	0.000288	CcSEcCtD
Etoricoxib—Vomiting—Dexamethasone—rheumatoid arthritis	3.13e-05	0.000288	CcSEcCtD
Etoricoxib—Decreased appetite—Methotrexate—rheumatoid arthritis	3.11e-05	0.000286	CcSEcCtD
Etoricoxib—Rash—Dexamethasone—rheumatoid arthritis	3.1e-05	0.000285	CcSEcCtD
Etoricoxib—Rash—Betamethasone—rheumatoid arthritis	3.1e-05	0.000285	CcSEcCtD
Etoricoxib—Dermatitis—Betamethasone—rheumatoid arthritis	3.1e-05	0.000285	CcSEcCtD
Etoricoxib—Dermatitis—Dexamethasone—rheumatoid arthritis	3.1e-05	0.000285	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	3.09e-05	0.000284	CcSEcCtD
Etoricoxib—Fatigue—Methotrexate—rheumatoid arthritis	3.08e-05	0.000284	CcSEcCtD
Etoricoxib—Headache—Dexamethasone—rheumatoid arthritis	3.08e-05	0.000283	CcSEcCtD
Etoricoxib—Headache—Betamethasone—rheumatoid arthritis	3.08e-05	0.000283	CcSEcCtD
Etoricoxib—Asthenia—Prednisone—rheumatoid arthritis	3.07e-05	0.000283	CcSEcCtD
Etoricoxib—Pain—Methotrexate—rheumatoid arthritis	3.06e-05	0.000282	CcSEcCtD
Etoricoxib—Pruritus—Prednisone—rheumatoid arthritis	3.03e-05	0.000279	CcSEcCtD
Etoricoxib—Feeling abnormal—Methotrexate—rheumatoid arthritis	2.95e-05	0.000271	CcSEcCtD
Etoricoxib—Diarrhoea—Prednisone—rheumatoid arthritis	2.93e-05	0.00027	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	2.93e-05	0.000269	CcSEcCtD
Etoricoxib—Nausea—Betamethasone—rheumatoid arthritis	2.92e-05	0.000269	CcSEcCtD
Etoricoxib—Nausea—Dexamethasone—rheumatoid arthritis	2.92e-05	0.000269	CcSEcCtD
Etoricoxib—Urticaria—Methotrexate—rheumatoid arthritis	2.84e-05	0.000262	CcSEcCtD
Etoricoxib—Dizziness—Prednisone—rheumatoid arthritis	2.83e-05	0.000261	CcSEcCtD
Etoricoxib—Abdominal pain—Methotrexate—rheumatoid arthritis	2.83e-05	0.00026	CcSEcCtD
Etoricoxib—Vomiting—Prednisone—rheumatoid arthritis	2.72e-05	0.000251	CcSEcCtD
Etoricoxib—Rash—Prednisone—rheumatoid arthritis	2.7e-05	0.000248	CcSEcCtD
Etoricoxib—Dermatitis—Prednisone—rheumatoid arthritis	2.7e-05	0.000248	CcSEcCtD
Etoricoxib—Headache—Prednisone—rheumatoid arthritis	2.68e-05	0.000247	CcSEcCtD
Etoricoxib—Hypersensitivity—Methotrexate—rheumatoid arthritis	2.64e-05	0.000243	CcSEcCtD
Etoricoxib—Asthenia—Methotrexate—rheumatoid arthritis	2.57e-05	0.000236	CcSEcCtD
Etoricoxib—Nausea—Prednisone—rheumatoid arthritis	2.54e-05	0.000234	CcSEcCtD
Etoricoxib—Pruritus—Methotrexate—rheumatoid arthritis	2.53e-05	0.000233	CcSEcCtD
Etoricoxib—Diarrhoea—Methotrexate—rheumatoid arthritis	2.45e-05	0.000225	CcSEcCtD
Etoricoxib—Dizziness—Methotrexate—rheumatoid arthritis	2.37e-05	0.000218	CcSEcCtD
Etoricoxib—Vomiting—Methotrexate—rheumatoid arthritis	2.27e-05	0.000209	CcSEcCtD
Etoricoxib—Rash—Methotrexate—rheumatoid arthritis	2.26e-05	0.000208	CcSEcCtD
Etoricoxib—Dermatitis—Methotrexate—rheumatoid arthritis	2.25e-05	0.000207	CcSEcCtD
Etoricoxib—Headache—Methotrexate—rheumatoid arthritis	2.24e-05	0.000206	CcSEcCtD
Etoricoxib—Nausea—Methotrexate—rheumatoid arthritis	2.12e-05	0.000196	CcSEcCtD
Etoricoxib—PTGS2—Metabolism—MED1—rheumatoid arthritis	1.08e-05	0.000135	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TLE3—rheumatoid arthritis	1.08e-05	0.000135	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—BGN—rheumatoid arthritis	1.08e-05	0.000135	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—POMC—rheumatoid arthritis	1.08e-05	0.000135	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NFATC1—rheumatoid arthritis	1.07e-05	0.000134	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—VCAM1—rheumatoid arthritis	1.06e-05	0.000132	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	1.06e-05	0.000132	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DQA1—rheumatoid arthritis	1.06e-05	0.000132	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ACAN—rheumatoid arthritis	1.05e-05	0.000131	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCR6—rheumatoid arthritis	1.02e-05	0.000128	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MED1—rheumatoid arthritis	1.02e-05	0.000127	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	1.01e-05	0.000126	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—TYK2—rheumatoid arthritis	1.01e-05	0.000126	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—TP53—rheumatoid arthritis	1.01e-05	0.000125	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—B3GNT2—rheumatoid arthritis	1e-05	0.000125	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ACP5—rheumatoid arthritis	1e-05	0.000125	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PLD4—rheumatoid arthritis	1e-05	0.000125	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NCF2—rheumatoid arthritis	9.96e-06	0.000124	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PLD4—rheumatoid arthritis	9.93e-06	0.000124	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SLC25A12—rheumatoid arthritis	9.89e-06	0.000123	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DQB1—rheumatoid arthritis	9.88e-06	0.000123	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SLC11A1—rheumatoid arthritis	9.85e-06	0.000123	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	9.82e-06	0.000122	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NFATC1—rheumatoid arthritis	9.78e-06	0.000122	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TRAF6—rheumatoid arthritis	9.71e-06	0.000121	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SH2B3—rheumatoid arthritis	9.71e-06	0.000121	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ACAN—rheumatoid arthritis	9.68e-06	0.000121	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GZMB—rheumatoid arthritis	9.65e-06	0.00012	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GC—rheumatoid arthritis	9.62e-06	0.00012	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGES—rheumatoid arthritis	9.62e-06	0.00012	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ACAN—rheumatoid arthritis	9.59e-06	0.00012	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PTK2—rheumatoid arthritis	9.56e-06	0.000119	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—VDR—rheumatoid arthritis	9.54e-06	0.000119	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ACP5—rheumatoid arthritis	9.45e-06	0.000118	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—B3GNT2—rheumatoid arthritis	9.45e-06	0.000118	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	9.44e-06	0.000118	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1A—rheumatoid arthritis	9.39e-06	0.000117	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL18—rheumatoid arthritis	9.37e-06	0.000117	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL2—rheumatoid arthritis	9.37e-06	0.000117	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL3—rheumatoid arthritis	9.37e-06	0.000117	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD40LG—rheumatoid arthritis	9.33e-06	0.000116	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL2—rheumatoid arthritis	9.3e-06	0.000116	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD8A—rheumatoid arthritis	9.23e-06	0.000115	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CSF2—rheumatoid arthritis	9.23e-06	0.000115	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—IL6—rheumatoid arthritis	9.2e-06	0.000115	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SAA1—rheumatoid arthritis	9.16e-06	0.000114	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD4—rheumatoid arthritis	9.1e-06	0.000114	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SLC25A12—rheumatoid arthritis	9.1e-06	0.000114	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NCF2—rheumatoid arthritis	9.09e-06	0.000113	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—BGN—rheumatoid arthritis	9.04e-06	0.000113	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SLC25A12—rheumatoid arthritis	9.02e-06	0.000113	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—AGER—rheumatoid arthritis	9e-06	0.000112	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—MMP9—rheumatoid arthritis	8.97e-06	0.000112	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NCF1—rheumatoid arthritis	8.97e-06	0.000112	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PLB1—rheumatoid arthritis	8.95e-06	0.000112	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—NFKB1—rheumatoid arthritis	8.88e-06	0.000111	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-B—rheumatoid arthritis	8.88e-06	0.000111	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGES—rheumatoid arthritis	8.85e-06	0.00011	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GC—rheumatoid arthritis	8.85e-06	0.00011	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GC—rheumatoid arthritis	8.78e-06	0.000109	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGES—rheumatoid arthritis	8.78e-06	0.000109	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—IL6—rheumatoid arthritis	8.63e-06	0.000108	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CD28—rheumatoid arthritis	8.63e-06	0.000108	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NR3C1—rheumatoid arthritis	8.59e-06	0.000107	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—BGN—rheumatoid arthritis	8.51e-06	0.000106	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PLD4—rheumatoid arthritis	8.49e-06	0.000106	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SAA1—rheumatoid arthritis	8.36e-06	0.000104	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	8.32e-06	0.000104	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ALOX5—rheumatoid arthritis	8.32e-06	0.000104	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL2RA—rheumatoid arthritis	8.32e-06	0.000104	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	8.32e-06	0.000104	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—C3—rheumatoid arthritis	8.25e-06	0.000103	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PLB1—rheumatoid arthritis	8.23e-06	0.000103	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-A—rheumatoid arthritis	8.23e-06	0.000103	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ACAN—rheumatoid arthritis	8.2e-06	0.000102	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NCF1—rheumatoid arthritis	8.18e-06	0.000102	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PLB1—rheumatoid arthritis	8.16e-06	0.000102	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—UBE2D1—rheumatoid arthritis	8.12e-06	0.000101	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ENO1—rheumatoid arthritis	8.1e-06	0.000101	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—VEGFA—rheumatoid arthritis	8.06e-06	0.000101	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—BDKRB2—rheumatoid arthritis	7.96e-06	9.93e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL12—rheumatoid arthritis	7.96e-06	9.93e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—VEGFA—rheumatoid arthritis	7.91e-06	9.86e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ADRBK1—rheumatoid arthritis	7.87e-06	9.82e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD28—rheumatoid arthritis	7.87e-06	9.82e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CRP—rheumatoid arthritis	7.85e-06	9.79e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MED1—rheumatoid arthritis	7.85e-06	9.79e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—NFKB1—rheumatoid arthritis	7.84e-06	9.78e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ALOX5—rheumatoid arthritis	7.83e-06	9.77e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC25A12—rheumatoid arthritis	7.71e-06	9.62e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—MAPK8—rheumatoid arthritis	7.71e-06	9.62e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TLR4—rheumatoid arthritis	7.52e-06	9.39e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-DRB1—rheumatoid arthritis	7.52e-06	9.38e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GC—rheumatoid arthritis	7.5e-06	9.35e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGES—rheumatoid arthritis	7.5e-06	9.35e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RASGRP1—rheumatoid arthritis	7.43e-06	9.26e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—UBE2D1—rheumatoid arthritis	7.41e-06	9.24e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SYK—rheumatoid arthritis	7.4e-06	9.23e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TGFB1—rheumatoid arthritis	7.4e-06	9.23e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	7.32e-06	9.13e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—B3GNT2—rheumatoid arthritis	7.29e-06	9.1e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ACP5—rheumatoid arthritis	7.29e-06	9.1e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PRKCQ—rheumatoid arthritis	7.27e-06	9.06e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TGFB1—rheumatoid arthritis	7.26e-06	9.05e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MED1—rheumatoid arthritis	7.22e-06	9e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ICAM1—rheumatoid arthritis	7.21e-06	9e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6ST—rheumatoid arthritis	7.21e-06	9e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ADRBK1—rheumatoid arthritis	7.18e-06	8.96e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MED1—rheumatoid arthritis	7.15e-06	8.92e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—STAT1—rheumatoid arthritis	7.14e-06	8.9e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL10—rheumatoid arthritis	7.04e-06	8.78e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PLB1—rheumatoid arthritis	6.97e-06	8.7e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD80—rheumatoid arthritis	6.94e-06	8.66e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—rheumatoid arthritis	6.91e-06	8.62e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ENO1—rheumatoid arthritis	6.78e-06	8.46e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ACP5—rheumatoid arthritis	6.71e-06	8.37e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—B3GNT2—rheumatoid arthritis	6.71e-06	8.37e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	6.67e-06	8.32e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	6.65e-06	8.3e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	6.65e-06	8.3e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PRKCQ—rheumatoid arthritis	6.63e-06	8.27e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—BGN—rheumatoid arthritis	6.57e-06	8.19e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	6.55e-06	8.17e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—STAT1—rheumatoid arthritis	6.51e-06	8.12e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6R—rheumatoid arthritis	6.44e-06	8.03e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MMP3—rheumatoid arthritis	6.42e-06	8.01e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ENO1—rheumatoid arthritis	6.39e-06	7.97e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	6.33e-06	7.89e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTK2—rheumatoid arthritis	6.18e-06	7.71e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MED1—rheumatoid arthritis	6.11e-06	7.62e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL5—rheumatoid arthritis	6.06e-06	7.56e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ALOX5—rheumatoid arthritis	6.04e-06	7.54e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—BGN—rheumatoid arthritis	6.04e-06	7.53e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—BGN—rheumatoid arthritis	5.99e-06	7.47e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—rheumatoid arthritis	5.97e-06	7.45e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CSF2—rheumatoid arthritis	5.97e-06	7.44e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	5.95e-06	7.42e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TYK2—rheumatoid arthritis	5.86e-06	7.31e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GC—rheumatoid arthritis	5.79e-06	7.22e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	5.79e-06	7.22e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	5.68e-06	7.09e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	5.68e-06	7.09e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SPP1—rheumatoid arthritis	5.61e-06	7e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6—rheumatoid arthritis	5.57e-06	6.95e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	5.56e-06	6.93e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	5.51e-06	6.87e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNG—rheumatoid arthritis	5.49e-06	6.85e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCR5—rheumatoid arthritis	5.46e-06	6.81e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	5.38e-06	6.71e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2RA—rheumatoid arthritis	5.38e-06	6.71e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—C3—rheumatoid arthritis	5.33e-06	6.65e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	5.31e-06	6.63e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD4—rheumatoid arthritis	5.3e-06	6.61e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—BGN—rheumatoid arthritis	5.12e-06	6.38e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CCR5—rheumatoid arthritis	4.98e-06	6.21e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—LEP—rheumatoid arthritis	4.97e-06	6.19e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ENO1—rheumatoid arthritis	4.93e-06	6.15e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6—rheumatoid arthritis	4.92e-06	6.14e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1B—rheumatoid arthritis	4.9e-06	6.11e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CAT—rheumatoid arthritis	4.88e-06	6.09e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL2—rheumatoid arthritis	4.88e-06	6.08e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MTHFR—rheumatoid arthritis	4.87e-06	6.07e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HLA-A—rheumatoid arthritis	4.85e-06	6.05e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	4.85e-06	6.04e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	4.85e-06	6.04e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MED1—rheumatoid arthritis	4.72e-06	5.88e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	4.71e-06	5.87e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—FN1—rheumatoid arthritis	4.68e-06	5.84e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6ST—rheumatoid arthritis	4.66e-06	5.82e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CAT—rheumatoid arthritis	4.6e-06	5.73e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—NFKB1—rheumatoid arthritis	4.57e-06	5.7e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	4.53e-06	5.65e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	4.49e-06	5.6e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MAPK8—rheumatoid arthritis	4.49e-06	5.6e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CD80—rheumatoid arthritis	4.49e-06	5.6e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	4.42e-06	5.51e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	4.39e-06	5.47e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	4.39e-06	5.47e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—POMC—rheumatoid arthritis	4.27e-06	5.32e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6ST—rheumatoid arthritis	4.25e-06	5.31e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	4.24e-06	5.29e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS2—rheumatoid arthritis	4.22e-06	5.27e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCL2—rheumatoid arthritis	4.17e-06	5.21e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6R—rheumatoid arthritis	4.16e-06	5.19e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	4.14e-06	5.17e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD80—rheumatoid arthritis	4.1e-06	5.11e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—MTHFR—rheumatoid arthritis	4.08e-06	5.08e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—BGN—rheumatoid arthritis	3.95e-06	4.93e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	3.87e-06	4.82e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	3.84e-06	4.79e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MTHFR—rheumatoid arthritis	3.84e-06	4.79e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6R—rheumatoid arthritis	3.8e-06	4.74e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TYK2—rheumatoid arthritis	3.79e-06	4.73e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	3.78e-06	4.71e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NOS3—rheumatoid arthritis	3.72e-06	4.64e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	3.63e-06	4.53e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CAT—rheumatoid arthritis	3.55e-06	4.42e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TYK2—rheumatoid arthritis	3.46e-06	4.31e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS3—rheumatoid arthritis	3.39e-06	4.23e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	3.3e-06	4.12e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL8—rheumatoid arthritis	3.3e-06	4.12e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CAT—rheumatoid arthritis	3.26e-06	4.07e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—POMC—rheumatoid arthritis	3.26e-06	4.07e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CAT—rheumatoid arthritis	3.23e-06	4.03e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2—rheumatoid arthritis	3.15e-06	3.93e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD4—rheumatoid arthritis	3.13e-06	3.9e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—POMC—rheumatoid arthritis	3.07e-06	3.83e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MMP9—rheumatoid arthritis	2.98e-06	3.72e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ALB—rheumatoid arthritis	2.97e-06	3.71e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	2.96e-06	3.7e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MTHFR—rheumatoid arthritis	2.96e-06	3.69e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NFKB1—rheumatoid arthritis	2.95e-06	3.68e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MAPK8—rheumatoid arthritis	2.9e-06	3.62e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—rheumatoid arthritis	2.87e-06	3.58e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—NOS3—rheumatoid arthritis	2.84e-06	3.55e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ALB—rheumatoid arthritis	2.8e-06	3.49e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CAT—rheumatoid arthritis	2.76e-06	3.45e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	2.72e-06	3.4e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	2.7e-06	3.37e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VEGFA—rheumatoid arthritis	2.68e-06	3.34e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—NOS3—rheumatoid arthritis	2.68e-06	3.34e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TGFB1—rheumatoid arthritis	2.46e-06	3.07e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—rheumatoid arthritis	2.45e-06	3.05e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—POMC—rheumatoid arthritis	2.37e-06	2.95e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	2.31e-06	2.88e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TGFB1—rheumatoid arthritis	2.24e-06	2.8e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—POMC—rheumatoid arthritis	2.18e-06	2.72e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—POMC—rheumatoid arthritis	2.16e-06	2.69e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ALB—rheumatoid arthritis	2.16e-06	2.69e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CAT—rheumatoid arthritis	2.13e-06	2.66e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NOS3—rheumatoid arthritis	2.06e-06	2.57e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—rheumatoid arthritis	2.03e-06	2.53e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ALB—rheumatoid arthritis	1.98e-06	2.48e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ALB—rheumatoid arthritis	1.97e-06	2.45e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	1.9e-06	2.37e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—rheumatoid arthritis	1.89e-06	2.35e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	1.88e-06	2.35e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—rheumatoid arthritis	1.85e-06	2.31e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—POMC—rheumatoid arthritis	1.84e-06	2.3e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	1.78e-06	2.22e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	1.74e-06	2.17e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	1.72e-06	2.15e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—rheumatoid arthritis	1.69e-06	2.11e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALB—rheumatoid arthritis	1.68e-06	2.1e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	1.61e-06	2.01e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	1.47e-06	1.83e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—POMC—rheumatoid arthritis	1.42e-06	1.78e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALB—rheumatoid arthritis	1.3e-06	1.62e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	1.24e-06	1.55e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	1.14e-06	1.42e-05	CbGpPWpGaD
